This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.Here is a sample of this item:PhotoMedex Appoints Christina L. Allgeier Chief Financial Officer 2009-11-05 14:10 ET - News Release
MONTGOMERYVILLE, Pa. -- (Business Wire)
PhotoMedex, Inc. (Nasdaq: PHMD) today announced that Christina L.
Allgeier has been promoted to the post of Chief Financial Officer of
PhotoMedex, Inc., effective November 4, 2009. Ms. Allgeier is a
Certified Public Accountant with significant SEC experience and joined
the Company as Corporate Controller in December 2002, when PhotoMedex
acquired Surgical Laser Technologies.
PhotoMedex’s President and CEO, Dennis M. McGrath, commented, “Christina
has been a true asset to the management team. This appointment not only
recognizes Christina’s past contributions but, even more significantly,
it expresses our confidence in her ability to assist us in successfully
navigating PhotoMedex into a substantially larger, more diverse
healthcare player.”
About PhotoMedex
PhotoMedex develops proprietary excimer laser and fiber optic systems
and techniques directed toward dermatological applications, with FDA
510(k) clearances to market the XTRAC® laser system for the
treatment of psoriasis, vitiligo, atopic dermatitis and leukoderma. The
Company also develops and markets products based on DNA Repair enzymes
and its patented, clinically proven Copper Peptide technology for skin
health, hair care and wound care. PhotoMedex sells directly to
dermatologists, plastic and cosmetic surgeons, and salons. ProCyte
brands include Neova®, Ti-Silc®, VitalCopper®,
Simple Solutions® and AquaSanté®. PhotoMedex also
develops, manufactures and markets medical laser products and services.
The remainder is available to Stockwatch subscribers.
If you would like to give the Stockwatch system a try,
click here for a free 30 day trial subscription. |
Top
Print this Page